Global Information
회사소개 | 문의 | 비교리스트

세계의 자궁내 피임 장치(IUD) 시장 예측

Global Intrauterine Contraceptive Devices Market Forecast 2019-2027

리서치사 Inkwood Research
발행일 2019년 04월 상품 코드 565784
페이지 정보 영문 107 Pages
가격
US $ 2,500 ₩ 3,017,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 3,621,000 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,431,000 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 자궁내 피임 장치(IUD) 시장 예측 Global Intrauterine Contraceptive Devices Market Forecast 2019-2027
발행일 : 2019년 04월 페이지 정보 : 영문 107 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 자궁내 피임 장치(IUD) 시장에 대해 조사했으며, 시장 개요, 종류·제품 종류·지역별 시장 동향, 시장 규모 예측(향후 9년간), 시장 성장 영향요인, 경쟁 구도, 주요 기업 개요 등의 정보를 전해드립니다.

제1장 조사 범위

제2장 조사 방법

제3장 주요 요약

  • 시장 개요
  • 주요 조사결과

제4장 시장 역학

  • 성장 촉진요인
  • 성장 저해요인
  • 시장 기회
  • 해결해야 할 과제

제5장 시장 세분화

  • 세계의 자궁내 피임 장치(IUD) 시장 : 종류별
    • 구리 IUD
    • 호르몬 IUD
  • 세계의 자궁내 피임 장치(IUD) 시장 : 제품별
    • MIRENA
    • SKYLA MARKET
    • PARAGARD
    • 기타 제품 시장

제6장 시장 분석

  • Five Forces 분석
  • 밸류체인 분석
  • 정책 및 규제 프레임워크
  • 시장 기회 매트릭스
  • 주요 기업
  • 주요 구매 기준

제7장 지역 세분화

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 프랑스
    • 독일
    • 스페인
    • 이탈리아
    • 기타
  • 아시아태평양
    • 인도
    • 중국
    • 일본
    • 한국
    • 기타
  • 기타 지역
    • 라틴아메리카
    • 중동 및 북아프리카

제8장 경쟁 구도

  • 주요 전략

제9장 기업 개요

  • 경쟁 전략
  • 시장 점유율 분석
  • ALLERGAN, PLC
  • BAYERS AG
  • DKT INTERNATIONAL
  • EGEMEN INTERNATIONAL
  • HLL LIFECARE LIMITED
  • KRISHCO MEDICAL PRODUCTS PVT.LTD
  • MEDISAFE DISTRIBUTION, INC.
  • MERIL LIFE SCIENCES PRIVATE LIMITED
  • MERCK & CO.
  • MELBEA
  • MONA LISA N.V
  • OCON MEDICAL LTD
  • OKAMOTO INDUSTRIES, INC
  • PFIZER
  • PREGNA
  • SMB CORPORATION
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  • TRIMEDIC SUPPLY NETWORK LTD
  • ZHEJIANG DAJI MEDICAL INSTRUMENTS CO., LTD.
LSH 17.11.06

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2019-2027 (IN $ BILLION)
  • TABLE 2. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2019-2027, (IN $ BILLION)
  • TABLE 3. GLOBAL COPPER ICD MARKET, BY REGION, 2019-2027 (IN $ BILLION)
  • TABLE 4. GLOBAL HORMONAL ICD MARKET, BY REGION, 2019-2027 (IN $ BILLION)
  • TABLE 5. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY PRODUCT, 2019-2027, (IN $ BILLION)
  • TABLE 6. GLOBAL MIRENA MARKET, BY REGION, 2019-2027 (IN $ BILLION)
  • TABLE 7. GLOBAL HARDWARE MARKET, BY REGION, 2019-2027 (IN $ BILLION)
  • TABLE 8. GLOBAL PARAGARD MARKET, BY REGION, 2019-2027 (IN $ BILLION)
  • TABLE 9. GLOBAL OTHER PRODUCTS MARKET, BY REGION, 2019-2027 (IN $ BILLION)
  • TABLE 10. OPPORTUNITY MATRIX
  • TABLE 11. VENDOR LANDSCAPE
  • TABLE 12. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY GEOGRAPHY, 2019-2027, (IN $ BILLION)
  • TABLE 13. NORTH AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY COUNTRY, 2019-2027 (IN $ BILLION)
  • TABLE 14. EUROPE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY COUNTRY, 2019-2027 (IN $ BILLION)
  • TABLE 15. ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY COUNTRY, 2019-2027 (IN $ BILLION)
  • TABLE 16. REST OF WORLD INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY REGION, 2019-2027 (IN $ BILLION)

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY TYPE, 2018 & 2027 (IN %)
  • FIGURE 2. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY COPPER ICD, 2019-2027 (IN $ BILLION)
  • FIGURE 3. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY HORMONAL ICD, 2019-2027 (IN $ BILLION)
  • FIGURE 4. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY MIRENA, 2019-2027 (IN $ BILLION)
  • FIGURE 1. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY SKYLA, 2019-2027 (IN $ BILLION)
  • FIGURE 2. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY PARAGARD, 2019-2027 (IN $ BILLION)
  • FIGURE 3. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, BY OTHER PRODUCTS, 2019-2027 (IN $ BILLION)
  • FIGURE 4. PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 5. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
  • FIGURE 6. UNITED STATES INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 7. CANADA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 8. UNITED KINGDOM INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 9. GERMANY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 10. FRANCE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 11. SPAIN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 12. ITALY INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 13. REST OF EUROPE INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 14. CHINA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 15. JAPAN INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 16. INDIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 17. SOUTH KOREA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 18. AUSTRALIA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 19. REST OF ASIA PACIFIC INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 20. LATIN AMERICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)
  • FIGURE 21. MIDDLE EAST & AFRICA INTRAUTERINE CONTRACEPTIVE DEVICES MARKET, 2019-2027 (IN $ BILLION)

KEY FINDINGS

The intrauterine contraceptive device is a T-shaped birth control device which is placed inside a woman's uterus to prevent pregnancy. Global intrauterine contraceptive devices market generated a revenue of $XX billion in 2018 & is projected to reach $5,253 million by 2027, at a CAGR of 3.87%. The base year considered for the study is 2018 & the estimated period is between 2019 & 2027.

The key factors favoring the use of IUD devices include the fact that these devices are safer and effective as compared to other methods and can be used on a long-term basis.

MARKET INSIGHTS

The global intrauterine contraceptive device market is mainly driven by increasing adoption of research activities coupled with the innovation of products is fueling the growth of this segment in the forecast period. The growth in the strategic initiatives by the company coupled with the low price of raw materials has further boosted the growth of the company. Also, the various government initiatives to curb the number of unsolicited pregnancies or abortions amongst the populace is hugely aiding the market expansion.

REGIONAL INSIGHTS

The global intrauterine contraceptive device market covers regions like North America, Asia-Pacific, Europe and the Rest of World. The Asia-Pacific region is expected to hold the largest share throughout the forecast period. China is predicted to be the major contributor to this market owing to the stringent government directives and raising awareness regarding the use of IUC devices.

Also, the Government of India is supporting research & development projects in IUD devices which will further fuel the market in the region. The increasing awareness among the woman population in the region is also boosting the growth of the Asia Pacific intrauterine contraceptive device market.

CONTRACEPTIVE INSIGHTS

Most of the companies are looking for strategies such as merger & acquisition, partnership, contracts, agreements & new product launch, to gain a competitive edge over other companies. Pregna International Ltd. is a reputed medical device company which deals with products like intrauterine devices (IUDs), intra-uterine enablers, and tubal rings. The company's product range includes various forms of IUDs, ex: spiral, copper coil, copper IUD, and loop. In another circumstance, the companies Medicines360 and Power partnered to help increase access to contraception for all women. Some of the major contending companies in the market are Merck & Co., HLL LifeCare Ltd., Meril Life Sciences Pvt. Ltd., Okamoto Industries Inc., Melbea, Medicines360, Pfizer, Pregna, DKT International, Medisafe Distribution Inc., Egemen International, Zhejiang Daji Medical Instruments Co., Ltd., Bayers AG, Krishco Medical Products Pvt. Ltd., Mona Lisa N.V., OCON Medical Ltd., SMB Corporation, Allergan PLC, Trimedic Supply Network Ltd., and Teva Pharmaceutical Industries Limited.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. INCREASED FUNDING IS SUPPORTING PUBLIC AWARENESS
    • 3.2.2. ASIA PACIFIC TO LEAD THE INTRAUTERINE CONTRACEPTIVE DEVICE MARKET
    • 3.2.3. INTRAUTERINE CONTRACEPTIVE DEVICE HAVE A LOW FAILURE RATE
    • 3.2.4. COPPER IUD HOLD THE LARGEST MARKET SHARE

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISING PREVALENCE OF UNPLANNED PREGNANCY
    • 4.2.2. TECHNOLOGICAL ADVANCEMENTS IN INTRAUTERINE CONTRACEPTIVE DEVICES
    • 4.2.3. GOVERNMENT INITIATIVES FOCUSING ON IMPROVED HEALTHCARE IN ASIAN COUNTRIES
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HIGH COST OF TREATMENT
    • 4.3.2. LOW ADOPTION OF INTRAUTERINE CONTRACEPTION IN DEVELOPING COUNTRIES
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. RATE OF UNINTENDED PREGNANCIES IS VERY HIGH
    • 4.4.2. VERY LOW FAILURE RATE OF IUD AND LOW SIDE-EFFECTS
  • 4.5. MARKET CHALLENGES
    • 4.5.1. HIGH RISK OF ECTOPIC PREGNANCY

5. MARKET BY TYPE

  • 5.1. COPPER ICD
  • 5.2. HORMONAL ICD

6. MARKET BY PRODUCT

  • 6.1. MIRENA
  • 6.2. SKYLA
  • 6.3. PARAGARD
  • 6.4. OTHER PRODUCTS

7. KEY ANALYTICS

  • 7.1. PORTER'S FIVE FORCE MODEL
    • 7.1.1. THREAT OF NEW ENTRANTS
    • 7.1.2. THREAT OF SUBSTITUTE
    • 7.1.3. BARGAINING POWER OF SUPPLIERS
    • 7.1.4. BARGAINING POWER OF BUYERS
    • 7.1.5. THREAT OF COMPETITIVE RIVALRY
  • 7.2. OPPORTUNITY MATRIX
  • 7.3. VENDOR LANDSCAPE

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. UNITED STATES
    • 8.1.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. UNITED KINGDOM
    • 8.2.2. GERMANY
    • 8.2.3. FRANCE
    • 8.2.4. SPAIN
    • 8.2.5. ITALY
    • 8.2.6. REST OF EUROPE
  • 8.3. ASIA PACIFIC
    • 8.3.1. CHINA
    • 8.3.2. JAPAN
    • 8.3.3. INDIA
    • 8.3.4. SOUTH KOREA
    • 8.3.5. AUSTRALIA
    • 8.3.6. REST OF ASIA PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. LATIN AMERICA
    • 8.4.2. MIDDLE EAST & AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. COMPANY PROFILES
    • 9.1.1. ALLERGAN PLC
    • 9.1.2. BAYERS AG
    • 9.1.3. HLL LIFECARE LTD.
    • 9.1.4. PFIZER
    • 9.1.5. MERCK & CO.
    • 9.1.6. OCON MEDICAL LTD.
    • 9.1.7. DKT INTERNATIONAL
    • 9.1.8. PREGNA
    • 9.1.9. SMB CORPORATION
    • 9.1.10. OKAMOTO INDUSTRIES INC.
    • 9.1.11. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
    • 9.1.12. EGEMEN INTERNATIONAL
    • 9.1.13. MEDISAFE DISTRIBUTION INC.
    • 9.1.14. MELBEA
    • 9.1.15. KRISHCO MEDICAL PRODUCTS PVT. LTD.
    • 9.1.16. ZHEJIANG DAJI MEDICAL INSTRUMENTS CO., LTD.
    • 9.1.17. MERIL LIFE SCIENCES PVT. LTD.
    • 9.1.18. MONA LISA N.V.
    • 9.1.19. TRIMEDIC SUPPLY NETWORK LTD.
    • 9.1.20. MEDICINES360
Back to Top
전화 문의
F A Q